XML 111 R79.htm IDEA: XBRL DOCUMENT v3.6.0.2
Related-Party Transactions - Additional Information (Details) - USD ($)
1 Months Ended 12 Months Ended
Jun. 30, 2012
Dec. 31, 2016
Dec. 31, 2015
Nov. 17, 2016
Related Party Transaction [Line Items]        
Common stock, shares issued   7,939,967 6,845,638  
Common stock value   $ 7,938 $ 6,844  
Revenue recognized   $ 5,132,730 $ 4,041,575  
QIAGEN Manchester Limited        
Related Party Transaction [Line Items]        
Agreement commencement period   2016-11    
Term of agreement   5 years    
Termination payment   $ 2,000,000    
QIAGEN North American Holdings Incorporation        
Related Party Transaction [Line Items]        
Common stock, shares issued       833,333
Common stock value       $ 2,000,000
Deferred revenue   $ 175,000    
Deferred revenue recognition period   5 years    
Revenue recognized   $ 4,375    
QIAGEN North American Holdings Incorporation | Share-based Compensation Award, Tranche Two        
Related Party Transaction [Line Items]        
Common stock value   2,000,000    
QIAGEN North American Holdings Incorporation | Common Stock        
Related Party Transaction [Line Items]        
Shares issued price per share       $ 2.40
Minimum | QIAGEN North American Holdings Incorporation        
Related Party Transaction [Line Items]        
Sale of stock in a financing transaction   $ 12,000,000    
Merck Capital Ventures, LLC        
Related Party Transaction [Line Items]        
Beneficial ownership   9.90% 11.10%  
Merck Sharp And Dohme Corporation        
Related Party Transaction [Line Items]        
Non-exclusive license agreement, milestone accrued or paid $ 0      
Merck Sharp And Dohme Corporation | Minimum        
Related Party Transaction [Line Items]        
Non-exclusive license agreement, contingent milestone payments $ 50,000      
Non-exclusive license agreement, future royalties 3.00%      
Merck Sharp And Dohme Corporation | Maximum        
Related Party Transaction [Line Items]        
Non-exclusive license agreement, contingent milestone payments $ 1,000,000      
Non-exclusive license agreement, future royalties 6.00%